DX Today | No-Hype Podcast & News About AI & DX
Novo Nordisk and OpenAI: End to End Pharma AI, the GLP One Race, and the Regulatory Crucible Ahead - May 3, 2026
Hosts Rick Spair and Laura discuss the partnership between Novo Nordisk and OpenAI to integrate AI across the drugmaker's operations, including drug discovery and manufacturing. They analyze the implications of this collaboration for the regulated pharmaceutical industry.